Schizophrenia Therapeutics Market Set to Witness an Uptick by 2021
Research analysts forecast the Global Schizophrenia Therapeutics Market to grow at a CAGR of 1.84% during the period 2017-2021.
(EMAILWIRE.COM, August 08, 2017 ) Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizophrenia is not as prevalent as other mental disorders, it affects 7 or 8 individuals out of 1,000 people. Globally, the disease affects 1% of the total population. Schizophrenic patients are usually diagnosed with low levels of dopamine and serotonin. These are major neurotransmitters in the brain and are responsible for transmitting nerve signals from one neuron to another neuron. Deficiency of these neurons in the brain leads to impairment of thinking, perception, and the activity of an individual. At present, the treatment regimen for this disease focuses on relieving symptoms. Thus, antipsychotic drugs are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.
Request sample copy of this report at: http://www.orbisresearch.com/contacts/request-sample/366574
The report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Schizophrenia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Other prominent vendors
Alkermes
Bristol-Myers Squibb
Market driver
Increasing expenditure on prescription drugs
For a full, detailed list, view our report
Market challenge
Technological advances in non-invasive neuromodulation devices
For a full, detailed list, view our report
Market trend
Increase in use of LAI antipsychotic drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Companies Mentioned:
AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Alkermes and Bristol-Myers Squibb.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/366574
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Request sample copy of this report at: http://www.orbisresearch.com/contacts/request-sample/366574
The report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Schizophrenia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Other prominent vendors
Alkermes
Bristol-Myers Squibb
Market driver
Increasing expenditure on prescription drugs
For a full, detailed list, view our report
Market challenge
Technological advances in non-invasive neuromodulation devices
For a full, detailed list, view our report
Market trend
Increase in use of LAI antipsychotic drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Companies Mentioned:
AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Alkermes and Bristol-Myers Squibb.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/366574
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results